These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 29790803)
21. Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer. Zhao Z; Li Y; Shukla R; Liu H; Jain A; Barve A; Cheng K Theranostics; 2019; 9(15):4508-4524. PubMed ID: 31285776 [TBL] [Abstract][Full Text] [Related]
22. Delivery of the bacterial nitroreductase gene into endothelial cells prolongs the survival of tumour-bearing mice by bystander mechanisms. Benouchan M; Do Nascimento F; Perret GY; Colombo BM Int J Oncol; 2006 Feb; 28(2):457-62. PubMed ID: 16391801 [TBL] [Abstract][Full Text] [Related]
23. Characterisation of enzyme prodrug gene therapy combinations in coated spheroids and vascular networks in vitro. Hunt MA; Li D; Hay MP; Currie MJ; Robinson BA; Patterson AV; Dachs GU J Gene Med; 2012 Jan; 14(1):62-74. PubMed ID: 22147660 [TBL] [Abstract][Full Text] [Related]
24. A mammalianized synthetic nitroreductase gene for high-level expression. Grohmann M; Paulmann N; Fleischhauer S; Vowinckel J; Priller J; Walther DJ BMC Cancer; 2009 Aug; 9():301. PubMed ID: 19712451 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy. Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560 [TBL] [Abstract][Full Text] [Related]
26. Repurposing Ruiz de Garibay G; García de Jalón E; Stigen E; Lund KB; Popa M; Davidson B; Safont MM; Rygh CB; Espedal H; Barrett TM; Haug BE; McCormack E Theranostics; 2021; 11(12):6044-6057. PubMed ID: 33897898 [TBL] [Abstract][Full Text] [Related]
28. Bystander or no bystander for gene directed enzyme prodrug therapy. Dachs GU; Hunt MA; Syddall S; Singleton DC; Patterson AV Molecules; 2009 Nov; 14(11):4517-45. PubMed ID: 19924084 [TBL] [Abstract][Full Text] [Related]
29. Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma. Chowdhury SM; Lee T; Bachawal SV; Devulapally R; Abou-Elkacem L; Yeung TA; Wischhusen J; Tian L; Dahl J; Paulmurugan R; Willmann JK J Control Release; 2018 Jul; 281():19-28. PubMed ID: 29758233 [TBL] [Abstract][Full Text] [Related]
30. Treatment of thyroid carcinoma cells with four different suicide gene/prodrug combinations in vitro. Nishihara E; Nagayama Y; Narimatsu M; Namba H; Watanabe M; Niwa M; Yamashita S Anticancer Res; 1998; 18(3A):1521-5. PubMed ID: 9673364 [TBL] [Abstract][Full Text] [Related]
31. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy. Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868 [TBL] [Abstract][Full Text] [Related]
32. The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite. Bridgewater JA; Knox RJ; Pitts JD; Collins MK; Springer CJ Hum Gene Ther; 1997 Apr; 8(6):709-17. PubMed ID: 9113510 [TBL] [Abstract][Full Text] [Related]
33. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid). Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340 [TBL] [Abstract][Full Text] [Related]
34. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells. Zhang C; Yuan W; Wu Y; Wan X; Gong Y Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044 [TBL] [Abstract][Full Text] [Related]
35. Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954. Lukashev AN; Fuerer C; Chen MJ; Searle P; Iggo R Hum Gene Ther; 2005 Dec; 16(12):1473-83. PubMed ID: 16390278 [TBL] [Abstract][Full Text] [Related]
36. Combined antitumor activity of the nitroreductase/CB1954 suicide gene system and γ-rays in HeLa cells in vitro. Teng G; Ju Y; Yang Y; Hua H; Chi J; Mu X Mol Med Rep; 2016 Dec; 14(6):5164-5170. PubMed ID: 27840931 [TBL] [Abstract][Full Text] [Related]
37. Polymeric Nanovectors Incorporated with Ganciclovir and HSV- Sawdon AJ; Zhang J; Peng S; Alyami EM; Peng CA Molecules; 2021 Mar; 26(6):. PubMed ID: 33801024 [TBL] [Abstract][Full Text] [Related]
38. Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems. Nouri FS; Wang X; Hatefi A J Control Release; 2015 Feb; 200():179-87. PubMed ID: 25575867 [TBL] [Abstract][Full Text] [Related]
39. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models. Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724 [TBL] [Abstract][Full Text] [Related]
40. The expression of bacterial nitroreductase in transgenic mice results in specific cell killing by the prodrug CB1954. Drabek D; Guy J; Craig R; Grosveld F Gene Ther; 1997 Feb; 4(2):93-100. PubMed ID: 9081711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]